This week, six Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
Currency-Hedged Funds: Hot, But Overhyped
The success of WisdomTree Japan Hedged Equity Fund has put the spotlight on currency-hedged funds, but the long-term data shows little benefit. More
Medical Device Stocks: Buy, Sell and Watch
Medtronic's Q4 earnings had medical device stocks buzzing this week. Take a look at which stocks to buy, sell and keep an eye on in the sector. More
5 Stocks With Awful Earnings Momentum — FNBN NAV SGK LGCY VNR
This week, these five stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader. More